All news

Novel radiopeptide shows high efficacy without high toxicity

Added: Tuesday 2 August 2011

A new radiopeptide called 213Bi-DOTATOC appears to show high efficacy in treating neuroendocrine tumours without high toxicity. Appropriate dosing is a key focus of research into alpha therapy, because of its high cytotoxicity; the new radiopeptide offers hope that more powerful, effective doses can be used.